Client-directed interventions to increase community access to breast, cervical, and colorectal cancer screening a systematic review.
Most major medical organizations recommend routine screening for breast, cervical, and colorectal cancers. Screening can lead to early detection of these cancers, resulting in reduced mortality. Yet not all people who should be screened are screened, either regularly or, in some cases, ever. This report presents the results of systematic reviews of effectiveness, applicability, economic efficiency, barriers to implementation, and other harms or benefits of interventions designed to increase screening for breast, cervical, and colorectal cancers by increasing community access to these services. Evidence from these reviews indicates that screening for breast cancer (by mammography) has been increased effectively by reducing structural barriers and by reducing out-of pocket client costs, and that screening for colorectal cancer (by fecal occult blood test) has been increased effectively by reducing structural barriers. Additional research is needed to determine whether screening for cervical cancer (by Pap test) can be increased by reducing structural barriers and by reducing out-of-pocket costs, whether screening for colorectal cancer (fecal occult blood test) can be increased by reducing out-of-pocket costs, and whether these interventions are effective in increasing the use of other colorectal cancer screening procedures (i.e., flexible sigmoidoscopy, colonoscopy, double contrast barium enema). Specific areas for further research are also suggested in this report.
Community Guide Branch, National Center for Health Marketing, CDC, Atlanta, Georgia, USA. rbaron@cdc.gov
Roy C
RC
Baron
Barbara K
BK
Rimer
Ralph J
RJ
Coates
Jon
J
Kerner
Geetika P
GP
Kalra
Stephanie
S
Melillo
Nancy
N
Habarta
Katherine M
KM
Wilson
Sajal
S
Chattopadhyay
Kimberly
K
Leeks
D003256:Community Participation; D005260:Female; D006297:Health Services Accessibility; D006801:Humans; D008297:Male; D008403:Mass Screening; D009369:Neoplasms / Q000175:diagnosis / Q000191:economics / Q000517:prevention & control*; D014481:United States